e-learning
resources
Paris 2018
Sunday, 16.09.2018
Studying novel biomarkers in asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Airway eosinophilia in severe asthma is associated with smoking history
A. Silberbrandt (Copenhagen, Denmark), A. Von Bülow (Copenhagen, Denmark), V. Backer (Copenhagen, Denmark), C. Porsbjerg (Copenhagen, Denmark)
Source:
International Congress 2018 – Studying novel biomarkers in asthma and COPD
Session:
Studying novel biomarkers in asthma and COPD
Session type:
Thematic Poster
Number:
948
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Silberbrandt (Copenhagen, Denmark), A. Von Bülow (Copenhagen, Denmark), V. Backer (Copenhagen, Denmark), C. Porsbjerg (Copenhagen, Denmark). Airway eosinophilia in severe asthma is associated with smoking history. 948
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Factors driving airway eosinophilia in prednisone-dependent severe asthma
Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma
Year: 2017
Predictors of sputum eosinophilia in severe asthma
Source: Virtual Congress 2020 – Clinical parameters in severe asthma
Year: 2020
Airway hyperresponsiveness and smoking, but not atopy, are associated with moderate and severe-persistent respiratory disease: analysis of a longitudinal birth cohort
Source: Annual Congress 2005 - Highlights of asthma epidemiology
Year: 2005
Smoking and severe persistent asthma
Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations
Year: 2018
Bronchiectasis and airway eosinophilia in severe asthma—is there an association?
Source: Virtual Congress 2020 – Phenotypes of obstructive diseases
Year: 2020
Special problems of severe asthma in childhood
Source: Eur Respir Mon 2011; 51: 59-81
Year: 2011
Cigarette smoking is decresed in severe asthma and associated with chronic rhinosinusitis without nasal polyps
Source: International Congress 2019 – Challenges in tobacco control and cessation
Year: 2019
Smoking and concomitant medication as risk factors for exacerbation of bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 45s
Year: 2005
Treatment of chronic cough associated with atopy
Source: Eur Respir J 2006; 28: Suppl. 50, 62s
Year: 2006
Smoking habit and bronchial hyperresponsiveness in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 39s
Year: 2006
Parameters associated with persistent airflow obstruction in chronic severe asthma
Source: Eur Respir J 2004; 24: 122-128
Year: 2004
Treatment of bronchial asthma and wheezing disorders: chronic
Source: ERS Skills Course 2016
Year: 2016
Benralizumab for severe asthma associated with extra-airway eosinophilic diseases
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020
Smoking status in the patients with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 152s
Year: 2004
The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
Heterogeneous response of airway eosinophilia to biologics in severe asthma patients
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021
Mast cells are associated with exacerbations and eosinophilia in children with severe asthma
Source: Eur Respir J 2016; 48: 1320-1328
Year: 2016
Tobacco smoking alters the relationship between airway inflammation and airway hyperresponsiveness in asthma
Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease
Year: 2012
Time domain and flow indices of bronchial hyperresponsiveness: association with asthma symptoms, atopy and smoking
Source: Eur Respir J 2002; 20: 86-91
Year: 2002
Natural history of asthma from childhood to adulthood
Source: Annual Congress 2005 - PG3 - Asthma: natural history, risk factors and overall management
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept